Endothelin-1 induces liver vasoconstriction through both ET(A) and ET(B) receptors

Journal of Hepatology

Volumn 26, Issue 5, 1997, Pages 1104-1110

  Zhang, Baimeng ^c   Calmus, Yvon ^c   Wen, Lanling ^c   Sogni, Philippe ^a   Lotersztajn, Sophie ^b   Houssin, Didier ^c   Weill, Bernard ^c  

^a Hôpital Cochin ^*  (France)

^b INSERM   (France)

^c NONE

Author keywords

BQ 123; BQ 3020; BQ 788; Endothelin 1; ET(A) receptor; ET(B) receptor; Isolated perfused rat liver; Sarafatoxin C

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR; RECEPTOR SUBTYPE;

ALCOHOL LIVER DISEASE; ANIMAL MODEL; ARTICLE; LIVER BLOOD FLOW; LIVER DISEASE; LIVER ISCHEMIA; LIVER PERFUSION; LIVER TRANSPLANTATION; MALE; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

EID: 0030970668     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80119-5     Document Type: Article

References (48)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular, endothelial cells. Nature. 332:1988;411-415.
2. Tran-Thi T, Kawada N, Decker K. Regulation of endothelin-1 action on the perfused rat liver. FEBS Lett. 318:1993;353-357.
3. Gandhi CR, Stephenson K, Olson MS. Endothelin, a potent peptide agonist in the liver. J Biol Chem. 265:1990;17432-17435.
4. 2+ oscillations, and activation of glycogenolysis. J Clin Invest. 87:1991;133-138.
5. Bluhm R, Frazer M, Vore M, Pinson C, Badr K. Endothelin 1 and 3: potent cholestatic agents secreted and excreted by the liver that interact with cyclosporine. Hepatology. 18:1993;961-968.
6. Grandhi C, Stephenson K, Olson M. A comparative study of endothelin and platelet-activating-factor-mediated signal transduction and prostaglandin synthesis in rat Kupffer cells. Biochem J. 281:1992;485-492.
7. Okumura S, Takei Y, Kawano S, Nagano K, Masuda E, Goto M, Tsuji S, Michida T, Chen SS, Kashiwagi T, Fusamoto H, Kamada T, Sato N. Vasoactive effect of endothelin-1 on rat liver in vivo. Hepatology. 19:1994;155-161.
8. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 348:1990;730-732.
9. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki S, Goto K, Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 348:1990;732-735.
10. Robert-Levine E. Endothelins. J Engl J Med. 333:1995;356-363.
11. Goetz KL, Wang BC, Madwed JB, Zhu JL, Leadley RJ Jr. Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol. 255:1988;R1064-R1068.
12. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet. 344:1994;852-854.
13. Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K, Marumo F. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest. 91:1993;1367-1373.
14. Filep JG, Herman F, Battistini B, Chabrier PE, Braquet P, Sirois P. Antiaggregatory and hypotensive effects of endothelial-1 in beagle dogs: role for prostacyclin. J Cardiovasc Pharmacol. 17:1991;S216-S218.
15. B receptors mediate contraction to endothelin-1 in human vessels. Circulation. 89:1994;1203-1208.
16. Zhang JX, Bauer M, Clemens MG. Vessel- and target cell-specific actions of endothelin-1 and endothelin-3 in rat liver. Am J Physiol. 269:1995;G269-G277.
17. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki T, Nagase T, Nishikibe M, Yano M. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA. 91:1994;4892-4896.
18. B) receptors. Life Sci. 51:1992;PL47-PL52.
19. Karaki H, Sudjarwo S, Hori M. Novel antagonist of endothelin ETB1 and ETB2 receptors, BQ 788: effects on blood vessel and small intestine. Biochem Biophys Res Commun. 205:1994;168-173.
20. Jouneaux C, Serradeil-Le Gal C, Garcia C, Préaux A, Hanoune J, Lotersztajn S. Biological effects of sarafotoxin in rat liver. Biochem Pharmacol. 43:1992;1146-1148.
21. Jouneaux C, Mallat A, Serradeil-Le Gal C, Goldsmith P, Hanoune J, Lotersztajn S. Coupling of endothelin B receptors to the calcium pump and phospholipase C via Gs and Gq in rat liver. J Biol Chem. 269:1994;1845-1851.
22. Marteau P, Ballet F, Chazouillères O, Chrétien Y, Rey C, Petit D, Poupon R. Effect of vasodilators on hepatic microcirculation in cirrhosis: a study in the isolated perfused rat liver. Hepatology. 9:1989;820-823.
23. Miller LL. Technique of isolated rat liver perfusion. Bartosek I, Guatain A, Miller LL. Isolated liver perfusion and its applications. 1973;11-52 Raven Press, New York.
24. Ballet F, Chrétien Y, Rey C, Poupon R. Norepinephrine: a potential modulators of the hepatic transport of taurocholate. A study in the isolated perfused rat liver. J Pharmacol Exp Ther. 240:1987;303-307.
25. Gores GJ, Kost LJ, LaRusso NF. The isolated perfused rat liver. Conceptual and practical considerations. Hepatology. 6:1986;511.
26. Huet PM, Kassissia J, Semret. Hemodynamics of isolated perfused liver. Ballet F., Thurman RG. Perfused Liver. 1993;39-50 Editions INSERM and John Libbey & Cy.
27. Vorobioff J, Bredfeldt JE, Gorszmann RJ. Increased blood flow through the portal system in cirrhotic rats. Gastroenterology. 87:1984;1120-1126.
28. Ossenberg FW, Denis P, Benhamou JP. Hepatic blood flow in the rat: effect of portocaval shunt. J Appl Physiol. 37:1974;806-808.
29. A receptor. Life Sci. 50:1992;247-255.
30. B receptor antagonist, BQ-788. Br J Pharmacol. 113:1994;1257-1262.
31. 15] endothelin-1 (11-21). (retraction of FEBS Lett 1992; 311: 12-6) FEBS Lett. 342:1994;103.
32. Grandhi C, Behal R, Harvey S, Nouchi T, Olson M. Hepatic effects of endothelin. Receptor characterization and endothelin-induced signal transduction in hepatocytes. Biochem J. 287:1992;897-904.
33. 125I] endotheln-1 by liver-derived cells. Arch Biochem Biophys. 305:1993;38-46.
34. Gondo K, Ueno T, Sakamoto M, Sakisaka S, Sata M, Tanikawa K. The endothelin-1 binding site in rat liver tissue: light-and electron-microscopic autoradiographic studies. Gastroenterology. 104:1993;1745-1749.
35. Housset C, Rockey D, Bissell D. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin-1. Proc Natl Acad Sci USA. 90:1993;9266-9270.
36. Rockey DC. Characterization of endothelin receptors mediating rat hepatic stellate cell contraction. Biochem Biophys Res Commun. 207:1995;725-731.
37. Mallat A, Fouassier L, Préaux A, Serradeil-Le Gal C, Raufaste D, Rosenbaum J, Dhumeaux D, Jouneaux C, Mavier P, Lotersztajn S. Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. J Clin Invest. 96:1995;42-49.
38. Kawada N, Tran-thi TA, Klein H, Decker K. The contraction of hepatic stellate (Ito) cells stimulation with vasoactive substances: Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem. 213:1993;815-823.
39. Friedman S, Rockey D, McGuire R, Maher J, Boyles J, Yamasaki G. Isolated hepatic lipocytes and Kupffer cells from normal human liver: morphological and functional characteristics in primary culture. Hepatology. 15:1992;234-243.
40. Oda M, Tsukada N, Watanabe N, Komatsu H, Yonei Y, Tsuchiya M. Functional implication of the sinusoidal endothelial fenestrae in the regulation of the hepatic microcirculation. Hepatology. 4:1984;754-761.
41. Bauer M, Zhang J, Bauer I, Clemens M. ET-1 induced alterations of hepatic microcirculation: sinusoidal and extrasinusoidal sites of action. Am J Physiol. 267:1994;G143-G149.
42. Oshita M, Takei Y, Kawano S, Yoshihara H, Hijiota, Fukui H, Goto M, Masuda M, Nishimura Y, Fusamoto H, Kamada T. Roles of endothelin-1 and nitric oxide in the mechanism for ethanol-induced vasoconstriction in rat liver. J Clin Invest. 91:1993;1337-1342.
43. Kourembanas S, Mardsen P, Mc Quillan L, Faller D. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest. 88:1991;1054-1057.
44. Watschinger B, Vychytil A, Schuller M, Hartter E, Traindl O. The pathophysiologic role of endothelin in acute vascular rejection after renal transplantation. Transplantation. 52:1991;743-746.
45. Gerbes AL, Moller Soren, Gulberg V, Henriksen JH. Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: role of splanchnic and renal passage and liver function. Hepatology. 21:1995;735-739.
46. Bernardi M, Gulberg V, Colantoni A, Trevisani F, Gasbarrini A, Gerbes AL. Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems. J Hepatol. 24:1996;161-168.
47. Pinzani M, Milani S, De Franco R, Grappone C, Caligiuri A, Gentilini A, Tosti-Guerra C, Maggi M, Failli P, Ruocco C, Gentilini P. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology. 110:1996;534-548.
48. Rockey DC, Weisiger RA. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: Implications for regulation of portal pressure and resistance. Hepatology. 24:1996;233-240.